RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Diabetic Cardiomyopathies
Accession: DOID:9006945
browse the term
Definition: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
Synonyms: exact_synonym: Diabetic Cardiomyopathy
xref: EFO:1001458 ; MESH:D058065
G
A2M
alpha-2-macroglobulin
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:21742475
RGD:10046044
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
G
ACE
angiotensin I converting enzyme
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:22595130
RGD:9685456
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACE2
angiotensin converting enzyme 2
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:22595130
RGD:9685456
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ACOT1
acyl-CoA thioesterase 1
ISO
associated with type 2 diabetes mellitus
RGD
PMID:23226270
RGD:13831128
NCBI chr14:73,490,933...73,543,796
Ensembl chr14:73,537,143...73,543,796
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
associated with Diabetes Mellitus, Type2;mRNA, protein:decreased expression:heart, serum
RGD
PMID:24669271
RGD:8695938
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADIPOR1
adiponectin receptor 1
ISO
associated with Diabetes Mellitus, Type2;mRNA, protein:decreased expression:heart, serum
RGD
PMID:24669271
RGD:8695938
NCBI chr 1:202,940,825...202,958,572
Ensembl chr 1:202,940,826...202,958,572
G
AGER
advanced glycosylation end-product specific receptor
treatment
ISO
associated with Diabetes Mellitus, Experimental; mRNA, protein:increased expression:heart (rat)
RGD
PMID:23251674 PMID:23251674
RGD:7244283 , RGD:7244283
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AGT
angiotensinogen
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29353218
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AGTR2
angiotensin II receptor type 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15587404 PMID:16025228
NCBI chr X:116,170,744...116,174,974
Ensembl chr X:116,170,744...116,174,974
G
AKT1
AKT serine/threonine kinase 1
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
APOA1
apolipoprotein A1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:18332268
NCBI chr11:116,835,751...116,837,622
Ensembl chr11:116,835,751...116,837,622
G
ATF6
activating transcription factor 6
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
ISO EXP
associated with Diabetes Mellitus, Experimental CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16685413 PMID:21441944
RGD:6771209
NCBI chr12:110,280,616...110,351,093
Ensembl chr12:110,280,756...110,351,093
G
ATP7A
ATPase copper transporting alpha
treatment
ISO
RGD
PMID:24927960
RGD:11341676
NCBI chr X:77,910,693...78,050,395
Ensembl chr X:77,910,690...78,050,395
G
BAD
BCL2 associated agonist of cell death
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:21296063
RGD:10053697
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BAX
BCL2 associated X, apoptosis regulator
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
associated with Diabetes Mellitus, Experimental associated with Diabetes Mellitus, Experimental;protein:increased phosphorylation:myocardium (mouse)
RGD
PMID:21296063 PMID:21474815
RGD:10053697 , RGD:11522727
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BRD4
bromodomain containing 4
ISO
mRNA,protein:increased expression:heart
RGD
PMID:30483785
RGD:597830144
NCBI chr19:15,235,519...15,332,539
Ensembl chr19:15,235,519...15,332,545
G
CASP12
caspase 12 (gene/pseudogene)
treatment
ISO
associated with Experimental Diabetes Mellitus
RGD
PMID:26869403
RGD:13782171
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:28992627
RGD:13782299
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:28992627
RGD:13782299
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CASP9
caspase 9
treatment
ISO
RGD
PMID:28992627
RGD:13782299
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CASQ2
calsequestrin 2
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:21441944
RGD:6771209
NCBI chr 1:115,700,021...115,768,714
Ensembl chr 1:115,698,038...115,837,921
G
CASR
calcium sensing receptor
ISO
protein:decreased expression:myocardium (rat)
RGD
PMID:22137362
RGD:7205677
NCBI chr 3:122,183,668...122,291,629
Ensembl chr 3:122,183,668...122,291,629
G
CFL1
cofilin 1
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:27576917
RGD:11568692
NCBI chr11:65,854,673...65,858,180
Ensembl chr11:65,823,022...65,862,026
G
CTNNB1
catenin beta 1
ISO
mRNA,protein:increased expression:heart
RGD
PMID:25586361
RGD:13524855
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
DDIT3
DNA damage inducible transcript 3
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
ERBB2
erb-b2 receptor tyrosine kinase 2
ISO
associated with Diabetes Mellitus, Experimental;mRNA:decreased expresssion:left ventricle myocardium
RGD
PMID:22285193
RGD:10449013
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
G
ERBB4
erb-b2 receptor tyrosine kinase 4
ISO
associated with Diabetes Mellitus, Experimental;mRNA:decreased expresssion:left ventricle myocardium
RGD
PMID:22285193
RGD:10449013
NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841
G
H19
H19 imprinted maternally expressed transcript
ameliorates
ISO
RGD
PMID:27796346 PMID:27903964 PMID:36044268
RGD:156430325 , RGD:156451660 , RGD:156430337
NCBI chr11:1,995,176...2,001,266
Ensembl chr11:1,995,165...2,004,552
G
HMOX1
heme oxygenase 1
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:23853776 PMID:23453443
RGD:9586347 , RGD:10412713
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HSP90B1
heat shock protein 90 beta family member 1
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
G
HSPA5
heat shock protein family A (Hsp70) member 5
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
IGF1
insulin like growth factor 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:11375343
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF2R
insulin like growth factor 2 receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:36462176
NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:23843977
RGD:7247697
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
INS
insulin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:20828608
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
G
INS-IGF2
INS-IGF2 readthrough
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:6225876
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
G
KLK1
kallikrein 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16129698
NCBI chr19:50,819,146...50,823,787
Ensembl chr19:50,819,146...50,823,787
G
LEPR
leptin receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35235096
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
ISO
associated with type 2 diabetes mellitus;protein:decreased expression:myocardium of ventricle (rat)
RGD
PMID:22146585
RGD:155883162
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:25907942
RGD:13800893
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:25907942
RGD:13800893
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MIR140
microRNA 140
ameliorates
ISO
RGD
PMID:36044268 PMID:31078585
RGD:156430337 , RGD:329347833
NCBI chr16:69,933,081...69,933,180
Ensembl chr16:69,933,081...69,933,180
G
MTOR
mechanistic target of rapamycin kinase
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
mRNA,protein:increased expression:heart
RGD
PMID:30483785
RGD:597830144
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
MYLK2
myosin light chain kinase 2
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:9005973
RGD:1580244
NCBI chr20:31,819,356...31,834,684
Ensembl chr20:31,819,308...31,834,689
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment ameliorates
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:23453443 PMID:36044268 PMID:23353773
RGD:10412713 , RGD:156430337 , RGD:10412721
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NOS3
nitric oxide synthase 3
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:29274332
RGD:13504685
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NOTCH1
notch receptor 1
treatment
ISO
RGD
PMID:32828943
RGD:405650202
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
G
NPPA
natriuretic peptide A
treatment
ISO
associated with Diabetes Mellitus, Experimental mRNA,protein:increased expression:heart
RGD
PMID:23497378 PMID:30483785
RGD:7297056 , RGD:597830144
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
G
NRG1
neuregulin 1
treatment
ISO
associated with Diabetes Mellitus, Experimental;protein:decreased expresssion:left ventricle myocardium
RGD
PMID:22285193 PMID:32828943
RGD:10449013 , RGD:405650202
NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
G
PLN
phospholamban
ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:heart left ventricle
RGD
PMID:22185592
RGD:7327207
NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
RGD
PMID:19317897
RGD:5509944
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
RYR2
ryanodine receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16685413
NCBI chr 1:237,042,184...237,833,988
Ensembl chr 1:237,042,184...237,833,988
G
SLC25A4
solute carrier family 25 member 4
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:18945756
NCBI chr 4:185,143,266...185,150,382
Ensembl chr 4:185,143,266...185,150,382
G
SLC8A1
solute carrier family 8 member A1
treatment
ISO
RGD
PMID:27058979
RGD:13628396
NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053
G
SPP1
secreted phosphoprotein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16980342
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
TERT
telomerase reverse transcriptase
treatment
ISO
associated with Diabetes Mellitus, Type 2
RGD
PMID:21264070
RGD:11038677
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17909696
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
XDH
xanthine dehydrogenase
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:23843977
RGD:7247697
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all